RAD140 (Testolone) is the newest compound in the SARMs family under development by Radius Health Inc. This compound’s discovery was published in 2010.
RAD 140 is used in the treatment of conditions such as muscle wasting and breast cancer
It has been shown that RAD140 has the unique property of countering the prostate-enlargement caused by testosterone use.
RAD 140 like all other SARMS, acts selectively and this allows it to have anabolic effects without the side effects seen with anabolic androgenic steroids (AAS). These side effects include prostate enlargement, suppression of natural testosterone production, head hair loss, gynecomastia and many others. What this translates to is that RAD140 interacts almost exclusively with the androgenic receptors in the muscle tissues and bones, but it does not activate these receptors in other parts of the body.
It has been determined that it would require 40% more of testosterone for the same muscle growth as with RAD140, and yet it would take 60 times more of RAD140 to even start showing any prostate related side effects. RAD 140 has a half-life of 48 hours.
*Everything in this description is publicly available and is intended for informational purposes only. For more detailed information, please conduct your own research and consult with experts in the field.